The family office investment fund is based in Taiwan. The fund focuses on healthcare, with investments including healthcare services as well as novel health technologies. The firm focuses on China, Taiwan and the US, and usually invests about $1 million per deal, but as the firm is a multi-stage investor, larger allocations are possible.
The fund is interested in medical devices, diagnostics and digital health, in addition to healthcare services. The firm is open to any indication area but has a particular interest in cardiology. The fund can make early stage investments but requires that the company at least have a working prototype/pilot product.
The fund primarily invests in companies that have operations in Asia but will also consider US-based companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment